Connect Biopharmaceuticals Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Public

  • Employees
  • 81

Employees

  • Stock Symbol
  • CNTB

Stock Symbol

  • Share Price
  • $0.68
  • (As of Wednesday Closing)

Connect Biopharmaceuticals General Information

Description

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Contact Information

Website
connectbiopharm.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • No. 6, Beijing West Road
  • Taicang Economic Development Zone
  • Taicang, Jiangsu 215400
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • No. 6, Beijing West Road
  • Taicang Economic Development Zone
  • Taicang, Jiangsu 215400
  • China
+86 0512

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Connect Biopharmaceuticals Stock Performance

As of 23-Apr-2025, Connect Biopharmaceuticals’s stock price is $0.68. Its current market cap is $37.6M with 55.3M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.68 $0.70 $0.51 - $2.08 $37.6M 55.3M 98.7K -$0.28

Connect Biopharmaceuticals Financials Summary

As of 31-Dec-2024, Connect Biopharmaceuticals has a trailing 12-month revenue of $26M.

In Thousands,
USD 		TTM 31-Dec-2024 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV (33,598) (33,598) (65,482) (142,605)
Revenue 26,033 26,033 0 0
EBITDA (19,198) (19,198) (66,489) (118,285)
Net Income (15,628) (15,628) (62,106) (118,091)
Total Assets 101,284 101,284 127,375 174,013
Total Debt 178 178 465 431
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Connect Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Connect Biopharmaceuticals‘s full profile, request access.

Request a free trial

Connect Biopharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation i
Drug Discovery
Taicang, China
81 As of 2023

Abingdon, United Kingdom
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Connect Biopharmaceuticals Competitors (62)

One of Connect Biopharmaceuticals’s 62 competitors is Adaptimmune Therapeutics, a Formerly VC-backed company based in Abingdon, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Poseida Therapeutics Formerly VC-backed San Diego, CA
BeiGene Formerly PE-Backed Beijing, China
Syndax Formerly VC-backed Waltham, MA
Dicerna Pharmaceuticals Formerly VC-backed Lexington, MA
You’re viewing 5 of 62 competitors. Get the full list »

Connect Biopharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Connect Biopharmaceuticals FAQs

  • When was Connect Biopharmaceuticals founded?

    Connect Biopharmaceuticals was founded in 2012.

  • Where is Connect Biopharmaceuticals headquartered?

    Connect Biopharmaceuticals is headquartered in Taicang, China.

  • What is the size of Connect Biopharmaceuticals?

    Connect Biopharmaceuticals has 81 total employees.

  • What industry is Connect Biopharmaceuticals in?

    Connect Biopharmaceuticals’s primary industry is Drug Discovery.

  • Is Connect Biopharmaceuticals a private or public company?

    Connect Biopharmaceuticals is a Public company.

  • What is Connect Biopharmaceuticals’s stock symbol?

    The ticker symbol for Connect Biopharmaceuticals is CNTB.

  • What is the current stock price of Connect Biopharmaceuticals?

    As of 23-Apr-2025 the stock price of Connect Biopharmaceuticals is $0.68.

  • What is the current market cap of Connect Biopharmaceuticals?

    The current market capitalization of Connect Biopharmaceuticals is $37.6M.

  • What is Connect Biopharmaceuticals’s current revenue?

    The trailing twelve month revenue for Connect Biopharmaceuticals is $26M.

  • Who are Connect Biopharmaceuticals’s competitors?

    Adaptimmune Therapeutics, Poseida Therapeutics, BeiGene, Syndax, and Dicerna Pharmaceuticals are some of the 62 competitors of Connect Biopharmaceuticals.

  • What is Connect Biopharmaceuticals’s annual earnings per share (EPS)?

    Connect Biopharmaceuticals’s EPS for 12 months was -$0.28.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »